Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This article was retracted on 29 March 2023

This article has been updated

Abstract

Background

The activation of hepatic stellate cells (HSCs) is involved in hepatic fibrogenesis and is regulated by the decreased expression of peroxisome proliferator-activated receptor γ (PPARγ). Rosiglitazone (RGZ) is a highly potent agonist of PPARγ.

Aims

To clarify molecular regulatory mechanism of RGZ in the activation of HSCs in hepatic fibrosis.

Methods

A mouse model of hepatic fibrosis was established by carbon tetrachloride with or without RGZ intervention. A vector carrying pcDNA-HOTAIR was constructed and injected into a mouse model. HSCs were isolated from liver tissue and activated by transforming growth factor-β. The expression of miR-124-3p, HOTAIR, Col1A1, α-SMA, and PPARγ mRNAs was measured by quantitative real-time PCR. The level of PPARγ was measured by Western blotting. The interaction between HOTAIR and PPARγ was assessed by RNA immunoprecipitation (RIP) and RNA pull-down. The target gene of miR-124-3p was determined by luciferase reporter assay and RNA interference approaches.

Results

The expression of Col1A1 and α-SMA was reduced after RGZ intervention. Different expressions of HOTAIR and miR-124-3p were observed in liver tissue and HSCs. The luciferase reporter assay and RNA interference approaches indicated that miR-124-3p negatively regulated HOTAIR expression. RIP and RNA pull-down results revealed that PPARγ was interacted by HOTAIR. The therapeutic effect of RGZ on hepatic fibrosis was reversed by overexpression of HOTAIR.

Conclusions

RGZ inhibits the activation of HSCs by up-regulating miR-124-3p. The silencing of HOTAIR by miR-124-3p in HSC activation provided the foundation to understand interactions of ncRNAs and potential treatment target in hepatic fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Change history

References

  1. Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62:S15–S24.

    Article  CAS  PubMed  Google Scholar 

  2. Mehal WZ, Schuppan D. Antifibrotic therapies in the liver. Semin Liver Dis. 2015;35:184–198.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hsu W-H, Lee BH, Hsu YW, Pan TM. Peroxisome proliferator-activated receptor-gamma activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling. J Agric Food Chem. 2013;61:6873–6879.

    Article  CAS  PubMed  Google Scholar 

  4. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature. 2000;405:421.

    Article  CAS  PubMed  Google Scholar 

  5. Marra F, Efsen E, Romanelli RG, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology. 2000;119:466–478.

    Article  CAS  PubMed  Google Scholar 

  6. Miyahara T, Schrum L, Rippe R, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000;275:35715–35722.

    Article  CAS  PubMed  Google Scholar 

  7. Lu Y, Ma D, Xu W, Shao S, Yu X. Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: a meta-analysis. J Diabetes Investig. 2015;6:78–86.

    Article  CAS  PubMed  Google Scholar 

  8. Zhao C, Chen W, Yang L, Chen L, Stimpson SA, Diehl AM. PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells. Biochem Biophys Res Commun. 2006;350:385–391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Asano T, Yamazaki H, Kasahara C, et al. Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyr imidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor. J Med Chem. 2012;55:7772–7785.

    Article  CAS  PubMed  Google Scholar 

  10. Yoshihara D, Kurahashi H, Morita M, et al. PPARgamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. Am J Physiol Renal Physiol. 2011;300:F465–F474.

    Article  CAS  PubMed  Google Scholar 

  11. Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157:77–94.

    Article  CAS  PubMed  Google Scholar 

  12. Zell S, Schmitt R, Witting S, Kreipe HH, Hussein K, Becker JU. Hypoxia induces mesenchymal gene expression in renal tubular epithelial cells: an in vitro model of kidney transplant fibrosis. Nephron Extra. 2013;3:50–58.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Gong M, Liang T, Jin S, et al. Methylation-mediated silencing of miR-124 facilitates chondrogenesis by targeting NFATc1 under hypoxic conditions. Am J Transl Res. 2017;9:4111–4124.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang D, Zhang H, Li M, et al. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res. 2014;114:67–78.

    Article  CAS  PubMed  Google Scholar 

  15. Jiang J, Gusev Y, Aderca I, et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res. 2008;14:419–427.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jiang X-P, Ai WB, Wan LY, Zhang YQ, Wu JF. The roles of microRNA families in hepatic fibrosis. Cell Biosci. 2017;7:34.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang Y, Hu M. Peroxisome proliferators activated receptor γ protects against acute lung injury alveolar macrophages inflammation by upregulating miR-124 expression. Chin J Lung Dis. 2015;8:160–165.

    Google Scholar 

  18. Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome. SPJ. 2005;309:1559–1563.

    CAS  Google Scholar 

  19. Sun M, Kraus WL. From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev. 2015;36:25–64.

    Article  CAS  PubMed  Google Scholar 

  20. Bian EB, Wang YY, Yang Y, et al. Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver. Biochimica et Biophysica Acta. 2017;1863:674–686.

    Article  CAS  PubMed  Google Scholar 

  21. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by non-coding RNAs. Cell. 2007;129:1311–1323.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Chiyomaru T, Fukuhara S, Saini S, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014;289:12550–12565.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bennett RG, Simpson RL, Hamel FG. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World J Gastroenterol. 2017;23:3999–4006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang K, Han X, Zhang Z, et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. Nat Commun. 2017;8:144.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, Kaneda K. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology. 1999;29:1760–1767.

    Article  CAS  PubMed  Google Scholar 

  26. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;28:2247–2250.

    Article  Google Scholar 

  27. Armoni M, Harel C, Karnieli E. PPARγ gene expression is autoregulated in primary adipocytes: ligand, sumoylation, and isoform specificity. Horm Metab Res. 2015;47:89–96.

    CAS  PubMed  Google Scholar 

  28. Zhang Q, Xiang S, Liu Q, et al. PPARγ antagonizes hypoxia-induced activation of hepatic stellate cell through cross mediating PI3K/AKT and cGMP/PKG signaling. PPAR Res. 2018. https://doi.org/10.1155/2018/6970407.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kweon S-M, Chi F, Higashiyama R, Lai K, Tsukamoto H. Wnt pathway stabilizes MeCP2 protein to repress PPAR-γ in activation of hepatic stellate cells. PLoS ONE. 2016;11:e0156111.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Troeger JS, Mederacke I, Gwak GY, et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology. 2012;143:1073. https://doi.org/10.1053/j.gastro.2012.06.036.

    Article  CAS  PubMed  Google Scholar 

  31. Morán-Salvador E, Titos E, Rius B, et al. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. J Hepatol. 2013;59:1045–1053.

    Article  PubMed  Google Scholar 

  32. Odegaard JI, Ricardo-Gonzalez RR, Eagle AR, et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 2008;7:496–507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, nonalcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385:956–965.

    Article  CAS  PubMed  Google Scholar 

  34. Yang J-J, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Therap Targets. 2014;18:1011–1021.

    Article  CAS  Google Scholar 

  35. Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol. 2012;3:49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2010;53:209–218.

    Article  PubMed  Google Scholar 

  37. Lakner AM, Steuerwald NM, Walling TL, et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology. 2012;56:300–310.

    Article  CAS  PubMed  Google Scholar 

  38. Liang YG, Liu ZT, Guo SX. Ultrasound reverses adriamycin-resistance in non-small cell lung cancer via positive regulation of BRAF-activated non-coding RNA (BANCR) expression. Clin Surg Res Commun. 2017;1:18–23.

    Article  Google Scholar 

  39. Zhang A, Zhao JC, Kim J, et al. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015;13:209–221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bhan A, Mandal SS. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 2015;1856:151–164.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15:565–576.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Song R, Walentek P, Sponer N, et al. miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature. 2014;510:115–120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sun Q, Csorba T, Skourti-Stathaki K, Proudfoot NJ, Dean C. R-loop stabilization represses antisense transcription at the Arabidopsis FLC locus. Science. 2013;340:619–621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ghosal S, Das S, Sen R, Basak P, Chakrabarti J. Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits. Front Genet. 2013;4:283.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucl Acids Res. 2010;38:5366–5383.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was funded by Zhejiang Provincial Natural Science Foundation (Grant Number: LY16H030014) and Zhejiang Provincial Medical Technology Project (Grant Number: 2019KY104) and Zhejiang Provincial Science Technology Project (Grant Number: 2015C37101).

Author information

Authors and Affiliations

  1. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Wenzhou Medical University, 205 Wenrui Avenue, Wenzhou, 325000, People’s Republic of China

    Shao-ce Zhi, Shi-zuan Chen, Yan-yan Li, Jun-jian Li, Yi-hu Zheng & Fu-xiang Yu

Authors
  1. Shao-ce Zhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shi-zuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan-yan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun-jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi-hu Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fu-xiang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yi-hu Zheng or Fu-xiang Yu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. All of these experiments in the current research were in compliance with the government policies and defined protocols.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Availability of data and material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Additional information

This article has been retracted. Please see the retraction notice for more detail:https://doi.org/10.1007/s10620-023-07926-0

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhi, Sc., Chen, Sz., Li, Yy. et al. RETRACTED ARTICLE: Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis. Dig Dis Sci 64, 1560–1570 (2019). https://doi.org/10.1007/s10620-019-5462-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-5462-8

Keywords

Search

Navigation